Navigation Links
New Jersey Decides to Support $500 M Stem Cell Research

The state of New Jersey has reached an agreement to support a $ 500 million research to further stem cell studies. This latest legislation comes// three years after the groundbreaking decision to legalise stem cell research, being only the second state in US to do so. The first bill for $ 270 million has already garnered enough support to gain the approval of the full assembly in the next week as per Assemblyman Neil M Cohen from D-Union who is one of the bills co-sponsors. The second bill for $ 230 million proposal would seek the assembly’s approval in the first two months of 2007. Both the senate president as well as the state Governor Corzine’s spokesman reported their support for the bills. New Jersey is presently racing with other states like California to gather funds for establishing research centers.

As per Cohen, setting up of stem cell research centers would spur the growth of the economy as well as the health standards in the state. It is pertinent to note that President Bush cancelled federal funding in 2001 quoting his opposition to destruction of embryo and cloning triggering off a race between states to lure beneficial funds.

Enmeshed in a tangle of ethical and moral concerns and doubts regarding borrowing, the state finally legalized the research in 2004, being only the second in US to do so. Stem cell research has several positive spin offs – It could lead to the cure of diabetes, cancer and other diseases. However the opponents oppose destruction of human embryo stressing that it amounts to murder. Amidst positive vibes for the project, there exist many a voice of dissent. Mr Leonard Lance, the minority Leader of the senate has voiced his doubts over the expenditure likely to be incurred. He has stated that the result may be an additional load on the burgeoning debt levels that exist in New Jersey. Other voices of dissent comes from people like John Tomicki who is the executive director of the League of American Families w ho opposes the embryonic research project on morality grounds and for the sheer risk it involves even while supporting the adult stem cell research.
MT
'"/>




Related medicine news :

1. Vladeck to head the University of Medicine and Dentistry of New Jersey
2. HIV Tests to Be Made Mandatory for Pregnant Women, Infants in New Jersey
3. Gene Decides How Much Exercise In Needed For The Elderly People
4. Campbell Decides To Boost Publicity about Prostate Cancer
5. Hospital Says There Is Time but Baby Decides Otherwise
6. Support therapy helps breast cancer patients
7. Support for patients with Leg Pain
8. WHO To Support Public Health Threats
9. Support Services found to Dramatically Impact Pediatric Health Care
10. Britney Spears Donates $50 000 To Support Cancer Patients
11. Supportive spouse help ease job strain on blood pressure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: